Founded in 1982 and based in Norcross, GA, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient/donor compatibility. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable

View all »   RSSRecent Releases

Oct 21, 2016
FDA approves Immucor's PreciseType® HEA Test to be used for screening blood donors for Sickle Cell Trait (SCT)

Oct 17, 2016
Immucor to Host Debt Investor Conference Call on Friday, October 21, 2016